Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Pacific Edge for InfoPages here.
Pacific Edge - Latest News [Page 2]
Pacific Edge Cxbladder Test Suite Adopted by Midcentral DHB
Thursday, 3 August 2017, 10:25 am | Pacific Edge
Pacific Edge Signs Agreement Extending Commercial Partnership with MidCentral District Health Board, to Encompass All Cxbladder Tests for Application Across the Clinical Pathway More >>
Pacific Edge Limited Full Year Results to 31 March 2017
Wednesday, 24 May 2017, 10:40 am | Pacific Edge
Steady growth in sales and laboratory throughput; strong progress on targeted transformational customers • Total revenue up 33% to $9.5m, including a 62% increase in operating revenue up to $8.1m with growth coming from new and existing commercial customers ... More >>
Callaghan Innovation Growth Grant for Pacific Edge
Tuesday, 21 March 2017, 3:19 pm | Pacific Edge
Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) is pleased to advise that it has received an additional grant of up to $3 million to its existing Growth Grant from Callaghan Innovation to enable further research and development of its ... More >>
Pacific Edge Undertakes $8m Share Placement
Wednesday, 15 February 2017, 12:02 pm | Pacific Edge
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB), has undertaken a $8.0 million share placement to institutional and other select investors in New Zealand. More >>
Pacific Edge Undertakes $8m Share Placement
Wednesday, 15 February 2017, 10:27 am | Pacific Edge
Cancer diagnostics company Pacific Edge Limited (NZX:PEB) has undertaken an $8.0 million share placement to institutional and other select investors in New Zealand. More >>
Official Launch of Cxbladder Monitor in the USA
Tuesday, 13 December 2016, 5:06 pm | Pacific Edge
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has commenced the official USA launch of its third bladder cancer diagnostic test, Cxbladder Monitor. More >>
Paper to Be Published in Prestigious Journal of Urology
Thursday, 8 December 2016, 2:15 pm | Pacific Edge
The prestigious American Journal of Urology has accepted for publication a paper confirming the superior performance of Pacific Edge’s Cxbladder Monitor test for the surveillance of bladder cancer recurrence, offering patients with bladder cancer ... More >>
Pacific Edge Named in Tin100 Top 10 List
Thursday, 20 October 2016, 12:33 pm | Pacific Edge
The growing success of cancer diagnostics company Pacific Edge has once again been recognised with company named in the 2016 TIN100 Top Ten list of Hot Emerging Companies for the second year in a row. More >>
Private Insurance Coverage Confirmed for Cxbladder
Thursday, 22 September 2016, 5:20 pm | Pacific Edge
Cancer diagnostics company, Pacific Edge (NZX:PEB) has advised that its Cxbladder diagnostics tests have been approved for reimbursement by a second major health insurance provider, nib Health Insurance in New Zealand. More >>
Chris Gallaher Elected New Chairman for Pacific Edge Board
Thursday, 25 August 2016, 3:33 pm | Pacific Edge
The Board of cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has announced the election of Mr Chris Gallaher as Chairman, replacing Mr Chris Swann who, as previously advised, is stepping down from the Board at today’s Annual Shareholders’ Meeting. More >>
Pacific Edge Reports Another Year of Commercial Progress
Thursday, 26 May 2016, 11:08 am | Pacific Edge
Cancer diagnostics company Pacific Edge Limited (NZX: PEB) has reported another year of commercial progress and growth as it continues to gain traction for its bladder cancer diagnostic products in the United States and other targeted markets. More >>
Confirmation of Director Appointment
Tuesday, 5 April 2016, 12:53 pm | Pacific Edge
Pacific Edge Limited (PEB:NZX) has today advised that David Levison’s appointment as a Director has been confirmed, effective as at 2 April 2016. More >>
Pacific Edge Announces New Commercial Partnership
Wednesday, 17 February 2016, 11:27 am | Pacific Edge
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has announced a new commercial partnership with Tolmar Australia Pty Limited, a specialised uro-oncology company which provides medicine and support to men with advanced prostate cancer. More >>
Pacific Edge Named in TIN100 Top 10 List
Thursday, 10 September 2015, 3:27 pm | Pacific Edge
Pacific Edge’s global growth and positive revenue trajectory has been recognised with the cancer diagnostics company named number 5 in the TIN100 Top Ten list of Hot Emerging Companies for 2015. More >>
Pacific Edge’s Cxbladder Detect Outperforms Other Diagnostic
Monday, 25 May 2015, 12:12 pm | Pacific Edge
Dunedin, NZ and Hershey, PA (May 25, 2015): Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The new research comparing and ranking four widely used tests ... More >>
Pacific Edge’s half year report
Thursday, 18 December 2014, 1:56 pm | Pacific Edge
• Signed Cxbaldder agreement with Multiplan, a large National Provider Network (NPN) in the US. This is the fourth agreement to be signed with NPNs since October 2013. More >>
Pacific Edge launches Cxbladder Triage
Monday, 8 December 2014, 2:23 pm | Pacific Edge
Dunedin-based Pacific Edge has released today the second product in its suite of diagnostic tests for the detection and management of bladder cancer. More >>
Pacific Edge Reports Commercial Progress and Revenue Growth
Friday, 28 November 2014, 12:43 pm | Pacific Edge
Pacific Edge Limited (NZX: PEB) has today announced its interim results for the six months to 30 September 2014, with strong revenue growth reflecting the Company’s positive commercial progress following the launch of its revolutionary bladder cancer ... More >>
Europe patent for colorectal cancer prognostic technology
Wednesday, 26 November 2014, 1:35 pm | Pacific Edge
The European Intellectual Property Office which operates across 38 countries including all European Union members, has awarded Pacific Edge a patent for its colorectal cancer prognostic technology. More >>
Correction on Pacific Edge Limited Patent Issue
Wednesday, 26 November 2014, 1:34 pm | Pacific Edge
Pacific Edge Limited ("the Company") advises the market that it has incorrectly posted the NZX release for the issue of its bladder cancer patent in Europe. More >>
